SFFS
IMGN

Stonehage Fleming Financial Services’s Immunogen Inc IMGN Stock Holding History

Stonehage Fleming Financial Services’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,277
Closed -$3K – 344
2016
Q3 		$3K Buy
+1,277
New +$3.71K ﹤0.01% 311

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Stonehage Fleming Financial Services's IMGN Position: Q4 2016 in Review

Stonehage Fleming Financial Services sold out of Immunogen Inc (IMGN) in Q4 2016, closing a stake of 1,277 shares — an estimated $3K sold.

Stonehage Fleming Financial Services first reported a position in IMGN in Q3 2016 and held it in 1 quarter. The position peaked at $3K in Q3 2016. 156 funds tracked by Wall St. Rank hold IMGN as of Q4 2016.

  • Stonehage Fleming Financial Services reported no remaining Immunogen Inc position as of Q4 2016 after selling out during the quarter.
  • Stonehage Fleming Financial Services sold 1,277 Immunogen Inc shares in Q4 2016, an estimated $3K.
  • Stonehage Fleming Financial Services first reported a position in Immunogen Inc in Q3 2016 and held it in 1 quarter.
  • Stonehage Fleming Financial Services's Immunogen Inc position peaked at $3K in Q3 2016.
  • 156 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2016.

Based on Stonehage Fleming Financial Services's 13F filing for Q4 2016, filed 11 Oct 2019.